‘World first’ as mass Covid-19 vaccine trial begins in Bradford. Professor leading study makes urgent plea for more BAME volunteers: The University of Bradford is hosting one of the world’s first mass Covid-19 vaccine trials, beginning today (Tues Oct 6).US biotechnology company Novavax is working with Bradford Institute for Health Research (BIHR), part of the […]
Read More… from University of Bradford Covid-19 vaccine trial
Never too late to fight back against pandemic: By Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization One million people have now been lost to COVID-19 and many more are suffering because of the pandemic. This milestone is a difficult moment for the world but there are glimmers of hope that encourage us now […]
Read More… from Never too late to fight back against pandemic
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy. A team of researchers led by Rudolf Valenta from MedUni Vienna’s Center for Pathophysiology, Infectiology and Immunology has now demonstrated that a protein contained in the BM32 vaccine against grass pollen allergy induces antibodies that prevent the hepatitis […]
Read More… from Chronic hepatitis B: vaccine against grass pollen allergy potential treatment
Imperial College London’s COVID-19 vaccine trial is expanding to additional sites throughout England. From next week, the ground-breaking vaccine, which has received more donations, will be trialled in six additional centres. Preclinical studies have shown that the vaccine produced highly specific antibodies against SARS-CoV-2 in mice, which were able to neutralise the virus. The vaccine […]
Read More… from Imperial COVID-19 vaccine trial expands to additional sites
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans and will test whether it is well-tolerated and produces an effective immune response against COVID-19. Imperial’s vaccine candidate is […]
Read More… from Imperial to begin first human trials of new Covid-19 vaccine
Scientists from the University of Bradford say they are ‘a step closer to finding a vaccine’ for tuberculosis after discovering a new variant of the disease in Africa. The new strain, known as Lineage 8, was found by chance in Rwanda – it has taken researchers two years to sequence and analyse its genome. The […]
Read More… from Tuberculosis: Scientists find “missing link” that moves them closer to cure
COVID-19 Series: Vaccines Episode 20 will be broadcast on zoom on Tue 9 Jun 2020 from 12:30pm to 1:00pm. Key speakers: Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London. Dr Thomas Breuer, Chief Medical Officer at GSK Vaccines. A safe and effective vaccine against COVID-19 is generally regarded as the only way […]
An Oxford-led study has identified the antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood. Researchers from the University of Oxford, along with partners from five institutions around the world, have identified the human antibodies that prevent the malaria parasite from entering blood cells, which may […]
Read More… from Identification of Protective Antibodies may be the Key to Effective Malaria Vaccine
Around 5 million UK women are invited to cervical screening each year, yet one in four do not attend to have smear tests. Regular cervical screening can reduce the risk of this largely preventable disease. However, research carried out by Jo’s Cervical Cancer Trust has revealed that body shame is responsible for many young women […]
The controversial documentary Vaxxed: From Cover Up to Catastrophe, is based on extensive recorded interviews with whistleblower, Dr William Thompson, a former senior scientist at the CDC, (Centres for Disease Control) the US agency concerned with safeguarding public health. The film looks at whether his claims – that he, and four others at the CDC, skewed data […]